Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Curr Opin Pharmacol. 2009 Jun 29;9(4):462–469. doi: 10.1016/j.coph.2009.05.007

Figure 2. Recombinant HLA-G produced in HEK293 cells does not kill CD14+ blood monocytes.

Figure 2

CD14+ blood monocytes incubated for 48 hr with 100 nM/ml of recombinant HLA-G5 or HLA-G6 (or no HLA-G) generated in HEK293 cells showed little change. Although some statistical significance suggesting increased cell numbers, the changes were not dramatic.